Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
- University of Oxford
- ;
- University of London
- Durham University
- University of Cambridge
- DURHAM UNIVERSITY
- KINGS COLLEGE LONDON
- Heriot Watt University
- Imperial College London
- Manchester Metropolitan University
- AALTO UNIVERSITY
- King's College London
- Nature Careers
- University of Birmingham
- University of Liverpool
- ; Royal Holloway, University of London
- ; University of Cambridge
- ; University of Copenhagen
- Birmingham City University
- City University London
- Kingston University
- Swansea University
- University of Bath
- University of Glasgow
- University of Newcastle
- University of Nottingham
- 16 more »
- « less
-
Field
-
have the necessary experience and skills to contribute to the research project by applying Drosophila genetics, genome editing, molecular biology, microscopy and bioinformatics to identify and test
-
is part of the Precision Musculoskeletal Care theme at the NIHR Biomedical Research Centre. The PDRA will help drive our activity in developing, validating, and testing a suit of new musculoskeletal
-
computational workflows on a high-performance cluster. You will test hypotheses using data from multiple sources, refining your approach as needed. The role also involves close collaboration with colleagues
-
testing, e.g. wear testing, corrosion testing, performance and durability testing. About the role: AMMIC is inviting ambitious and talented individuals with a background in materials science/engineering
-
programme. The particular emphasis of the project will be to examine the interaction between atherosclerotic plaque macrophages and neutrophil extracellular traps and how it impacts cellular function and
-
will employ a multi-disciplinary approach, including protein/nucleic acid biochemistry, bacterial genetics, and phage biology to test and generate hypotheses. You will develop new ideas and approaches
-
will test the ability of known and near-clinical drugs to reverse or block these changes and ultimately aims to develop a preventive breast cancer vaccine for individuals with inherited predisposition
-
Institute and RiverD International. The successful candidate will adapt existing and develop and test new methods for detecting metastatic lymph nodes based on their molecular signatures as captured by AF and
-
advanced patient-derived tumour models and use them to test promising therapeutic targets that exploit vulnerabilities caused by loss of the SMARCB1 gene. This role offers an excellent opportunity to further
-
). This consortium pulls together expertise from all over the University, including in diagnostics, data science, drug and vaccine design, preclinical testing and clinical testing and brings it to bear on tuberculosis